Cheng-Yu Kuo

A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)

C. Hsiao, W. Chung, Wei-Yao Wang, 2020, medRxiv.

Clinical characteristics and treatment outcomes of SARS-CoV-2 delta variant outbreak, Pingtung, Taiwan, June 2021

Ming‐Lung Yu, Chung‐Feng Huang, C. Dai, 2022, Journal of the Formosan Medical Association.

Clinical features and prognostic factors of emphysematous urinary tract infection.

Chun-Yu Lin, Yen-Hsu Chen, P. Lu, 2009, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials

Sean M. O'Brien, B. Abella, D. Angus, 2020, medRxiv.

Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports.

S. Belknap, D. Ganger, A. Evens, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan

P. Lu, W. Hung, S. Tseng, 2015, PloS one.

Leucocin C-607, a Novel Bacteriocin from the Multiple-Bacteriocin-Producing Leuconostoc pseudomesenteroides 607 Isolated from Persimmon

F. Yanagida, Yi-sheng Chen, Hui-chung Wu, 2018, Probiotics and Antimicrobial Proteins.

Resistance to first- and second-line antituberculosis drugs in Southern Taiwan: Implications for empirical treatment.

Wen-Hung Wang, Yen-Hsu Chen, P. Lu, 2017, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.